Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014404 · ClinicalTrials.gov registry record · Phase 2
Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00014404: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00014404 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00014404, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of celecoxib may be an effective way to prevent the further development of precancerous lesions in the mouth. PURPOSE: Randomized phase II trial to compare the effectiveness of different regimens of celecoxib in treating patients who have precancerous lesions in the mouth.
Interventions
- DRUG celecoxib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10 |
| Phase | Phase 2 |
What the finished NCT00014404 record still lists
NCT00014404 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which celecoxib is the first listed.
NCT00014404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00014404 about?
NCT00014404 is a clinical study titled "Celecoxib in Treating Patients With Precancerous Lesions of the Mouth". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of celecoxib may be an effective way to prevent the further development of precancerous lesions in the mouth. PURPOSE: Randomized phase II trial to compare the effectiveness of differ...
What is the current status of trial NCT00014404?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-10.
What interventions are being tested in trial NCT00014404?
The interventions under investigation include: celecoxib (DRUG).
Who is sponsoring clinical trial NCT00014404?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia